Burrows Scott L
Chief Financial Officer
CIK: 1853327
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,775 | $87.55 | $505,601.25 | View Details Filing |
| Jul 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 1,725 | $88.37 | $152,438.25 | View Details Filing |
| Jun 25, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,000 | $87.12 | $435,600.00 | View Details Filing |
| Jun 25, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 10,000 | $87.14 | $871,400.00 | View Details Filing |
| Jun 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 1,801 | $69.75 | $125,619.75 | View Details Filing |
| Jun 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 2,599 | $70.77 | $183,931.23 | View Details Filing |
| Jun 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 3,100 | $72.06 | $223,386.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 12,500 | $71.37 | $892,125.00 | View Details Filing |